SEATTLE, WA -- (Marketwired) -- 11/18/13 -- Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company, today announced that on November 14, 2013, Atossa attended a pre-510(k) submission meeting with the Food and Drug Administration and discussed the regulatory pathway and data requirements t ...
↧